University of Minnesota Cancer Center

Minneapolis, Minnesota 55455

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Relapsed/Refractory Indolent B Cell Non-Hodgkin Lymphoma Clinical Trial
QUILT-3.002: ALT-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials